Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Articaine plus clonidine for inferior alveolar nerve block in irreversible pulpitis
IRCT201706022541N6Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of articaine and clonidine in irreversible pulpitis, sponsored by Isfahan University of Medical Sciences. Started Jul 2017; status: completed.
02
Drugs
articaineclonidine
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on IRCT201706022541N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201706022541N6.